Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Hepatobiliary Cancers × Gastrointestinal × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1274 Pancreatic Neoplasms 735 Stomach Neoplasms 608 Carcinoma, Hepatocellular 571 Carcinoma, Non-Small-Cell Lung 473 Neoplasms 415 Breast Neoplasms 323 Ovarian Neoplasms 294 Colonic Neoplasms 293 Neoplasm Metastasis 292 Esophageal Neoplasms 262 Liver Neoplasms 241 Melanoma 220 Lung Neoplasms 212 Squamous Cell Carcinoma of Head and Neck 185 Carcinoma, Renal Cell 160 Head and Neck Neoplasms 151 Cholangiocarcinoma 151 Prostatic Neoplasms 147 Triple Negative Breast Neoplasms 143 Rectal Neoplasms 141 Endometrial Neoplasms 137 Uterine Cervical Neoplasms 130 Gastrointestinal Neoplasms 127 Urinary Bladder Neoplasms 126 Biliary Tract Neoplasms 119 Sarcoma 93 Gastrointestinal Stromal Tumors 93 Esophageal Squamous Cell Carcinoma 90 Small Cell Lung Carcinoma 78

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06252753 2025-12-26

LIVER-R

AstraZeneca

Gastrointestinal

Hepatobiliary Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡